Phase II Trial of Elotuzumab with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) in the Post-Daratumumab Progression Setting
Ailawadhi, Sikander, Parrondo, Ricardo D, Laplant, Betsy, Alegria, Victoria R., Elliott, Jamie B, Sher, Taimur, Paulus, Aneel, Chapin, Dustin, Heslop, Keisha, Chanan-Khan, Asher, Roy, Vivek
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM)
Ailawadhi, Sikander, Parrondo, Ricardo D, Laplant, Betsy, Alegria, Victoria R., Elliott, Jamie B, Zimmerman, Ashley, Heslop, Keisha, Chapin, Dustin, Sher, Taimur, Roy, Vivek, Rasheed, Ahsan, Paulus, Aneel, Chanan-Khan, Asher
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
Parrondo, Ricardo D., Dutta, Navnita, LaPlant, Betsy R., Elliott, Jamie, Fernandez, Andre, Zimmerman, Ashley, Cicco, Gina, Han, Bing, Heslop, Keisha, Chapin, Dustin, Sher, Taimur, Roy, Vivek, Rasheed, Ahsan, Das, Saurav, Chanan‐Khan, Asher A., Paulus, Aneel, Ailawadhi, Sikander
Published in British journal of haematology (01.05.2024)
Published in British journal of haematology (01.05.2024)
Get full text
Journal Article
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Ailawadhi, Sikander, Parrondo, Ricardo D, Dutta, Navnita, Han, Bing, Ciccio, Gina, Cherukuri, Yesesri, Alegria, Victoria R, LaPlant, Betsy R, Roy, Vivek, Sher, Taimur, Edwards, Brett, Lanier, Stephanie, Manna, Alak, Heslop, Keisha, Caulfield, Thomas, Maldosevic, Emir, Storz, Peter, Manochakian, Rami, Asmann, Yan, Chanan-Khan, Asher A, Paulus, Aneel
Published in Cancers (12.01.2023)
Published in Cancers (12.01.2023)
Get full text
Journal Article